Source |
Alliance of Genome Resources |
Category | ID | Classification term | Gene | Evidence | Inferred from | Organism | Reference |
---|---|---|---|---|---|---|---|
Molecular Function | GO:0055102 | lipase inhibitor activity | APOC2 | IDA | Human | PMID:182536 | |
Molecular Function | GO:0008289 | lipid binding | APOC2 | IDA | Human | PMID:10727238 | |
Molecular Function | GO:0060230 | lipoprotein lipase activator activity | APOC2 | IDA | Human | PMID:10727238 | |
Molecular Function | GO:0060230 | lipoprotein lipase activator activity | APOC2 | IDA | Human | PMID:270715 | |
Molecular Function | GO:0140677 | molecular function activator activity | APOC2 | EXP | Human | PMID:15209504 | |
Molecular Function | GO:0016004 | phospholipase activator activity | APOC2 | IDA | Human | PMID:10727238 | |
Molecular Function | GO:0043274 | phospholipase binding | APOC2 | IPI | UniProtKB:P11151 | Human | PMID:10727238 |
Molecular Function | GO:0005515 | protein binding | APOC2 | IPI | UniProtKB:P49638 | Human | PMID:32296183 |
Cellular Component | GO:0042627 | chylomicron | APOC2 | IDA | Human | PMID:8245722 | |
Cellular Component | GO:0005615 | extracellular space | APOC2 | IDA | Human | PMID:10727238 | |
Cellular Component | GO:0034363 | intermediate-density lipoprotein particle | APOC2 | IDA | Human | PMID:17336988 | |
Cellular Component | GO:0034362 | low-density lipoprotein particle | APOC2 | IDA | Human | PMID:8245722 | |
Cellular Component | GO:0034366 | spherical high-density lipoprotein particle | APOC2 | IDA | Human | PMID:16682745 | |
Cellular Component | GO:0034361 | very-low-density lipoprotein particle | APOC2 | IDA | Human | PMID:8245722 | |
Biological Process | GO:0033344 | cholesterol efflux | APOC2 | IDA | Human | PMID:11162594 | |
Biological Process | GO:0034382 | chylomicron remnant clearance | APOC2 | IDA | Human | PMID:4020294 | |
Biological Process | GO:0060216 | definitive hemopoiesis | apoc2 | IMP | ZFIN:ZDB-GENO-190507-1 | Zfish | PMID:29615667 |
Biological Process | GO:0034384 | high-density lipoprotein particle clearance | APOC2 | IMP | Human | PMID:15778093 | |
Biological Process | GO:0006629 | lipid metabolic process | apoc2 | IMP | ZFIN:ZDB-MRPHLNO-210401-1 | Zfish | PMID:32768193 |
Biological Process | GO:0042159 | lipoprotein catabolic process | apoc2 | IMP | Zfish | PMID:22581286 | |
Biological Process | GO:0042953 | lipoprotein transport | Apoc2 | IDA | Rat | PMID:4020294|RGD:1599181 | |
Biological Process | GO:0032375 | negative regulation of cholesterol transport | APOC2 | IMP | Human | PMID:15778093 | |
Biological Process | GO:0045833 | negative regulation of lipid metabolic process | APOC2 | IDA | Human | PMID:182536 | |
Biological Process | GO:0048261 | negative regulation of receptor-mediated endocytosis | APOC2 | IDA | Human | PMID:1917954 | |
Biological Process | GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | APOC2 | IDA | Human | PMID:1917954 | |
Biological Process | GO:0033700 | phospholipid efflux | APOC2 | IDA | Human | PMID:11162594 | |
Biological Process | GO:0045723 | positive regulation of fatty acid biosynthetic process | APOC2 | IDA | Human | PMID:10727238 | |
Biological Process | GO:0051006 | positive regulation of lipoprotein lipase activity | APOC2 | IDA | Human | PMID:10727238 | |
Biological Process | GO:0051006 | positive regulation of lipoprotein lipase activity | APOC2 | IDA | Human | PMID:15878877 | |
Biological Process | GO:0010518 | positive regulation of phospholipase activity | APOC2 | IDA | Human | PMID:10727238 | |
Biological Process | GO:0060697 | positive regulation of phospholipid catabolic process | APOC2 | IDA | Human | PMID:10727238 | |
Biological Process | GO:0010898 | positive regulation of triglyceride catabolic process | APOC2 | IDA | Human | PMID:10727238 | |
Biological Process | GO:0009410 | response to xenobiotic stimulus | Apoc2 | IEP | Rat | PMID:9888873|RGD:1599178 | |
Biological Process | GO:0070328 | triglyceride homeostasis | APOC2 | IMP | Human | PMID:17018885 |
EXP Inferred from experiment |
IDA Inferred from direct assay |
IEP Inferred from expression pattern |
IGI Inferred from genetic interaction |
IMP Inferred from mutant phenotype |
IPI Inferred from physical interaction |
HTP Inferred from High Throughput Experiment |
HDA Inferred from High Throughput Direct Assay |
HMP Inferred from High Throughput Mutant Phenotype |
HGI Inferred from High Throughput Genetic Interaction |
HEP Inferred from High Throughput Expression Pattern |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|